Synthetic RNA 'Nanostars' Create Programmable Compartments in Bacteria

Why It Matters

The technology offers a synthetic route to spatially organize biochemical pathways in bacteria, boosting efficiency and control in biomanufacturing. It expands the synthetic‑biology toolbox with RNA‑based organelles previously unavailable in prokaryotes.

Key Takeaways

• RNA nanostars self‑assemble into membraneless organelles in E. coli.
• Organelles form and dissolve reversibly with temperature changes.
• Aptamer‑bearing arms capture and concentrate target proteins.
• Enables programmable intracellular compartments for biomanufacturing.
• First demonstration of synthetic RNA organelles in bacteria.

Pulse Analysis

Synthetic biology has long grappled with the lack of natural compartmentalization in bacterial hosts. While eukaryotic cells rely on membrane‑bound organelles to segregate metabolic pathways, prokaryotes typically mix all reactions in a single cytosol, limiting pathway efficiency and product purity. Prior attempts to impose order—such as protein scaffolds, engineered microcompartments, or lipid vesicles—have faced challenges in scalability and dynamic control. The Cambridge team’s RNA nanostars introduce a fundamentally different approach, leveraging the inherent programmability of nucleic acids to create membraneless, phase‑separated domains that can be tuned on demand.

The nanostars consist of four RNA strands designed to hybridize through complementary base‑pairing, forming a star‑shaped scaffold that undergoes liquid‑liquid phase separation inside the cell. Fluorescence microscopy confirmed that these condensates appear as distinct foci and dissolve when the temperature is lowered, evidencing reversible, temperature‑responsive behavior. By grafting an aptamer onto one arm, the researchers demonstrated selective capture of fluorescent proteins, concentrating them within the organelle and effectively creating a micro‑reactor. This modularity means that different functional modules—enzymes, binding motifs, or signaling elements—can be swapped in without redesigning the entire scaffold.

The implications for biomanufacturing are immediate. Concentrating enzymes and substrates within a defined volume can accelerate reaction rates, reduce side‑product formation, and simplify downstream purification by co‑localizing target proteins. Moreover, the reversible nature of the compartments allows dynamic regulation of metabolic fluxes, a feature valuable for producing therapeutics that require tight quality control. Future work will likely explore scaling the system to industrial strains, integrating multiple nanostar designs for layered compartmentalization, and extending the concept to other microbes. If these hurdles are overcome, RNA‑based synthetic organelles could become a cornerstone of next‑generation microbial factories, reshaping how the biotech industry engineers cellular production lines.